Histological improvement after anti-viral treatment for chronic hepatitis B virus infection
- 31 March 1989
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 8 (2), 218-225
- https://doi.org/10.1016/0168-8278(89)90010-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Lymphoblastoid and recombinant α-A Interferon therapy of chronic hepatitis B virus infection: The royal free hospital experienceJournal of Hepatology, 1986
- Diverse virological, histopathological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infectionJournal of Hepatology, 1986
- Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type BHepatology, 1986
- A randomized study of the effects of adenine arabinoside 5′-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replicationHepatology, 1985
- Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.Gut, 1985
- Clinical and histological features of delta infection in chronic hepatitis B virus carriers.Journal of Clinical Pathology, 1985
- MORTALITY OF HEPATITIS B POSITIVE BLOOD DONORS IN ENGLAND AND WALESThe Lancet, 1985
- Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replicationLiver International, 1984
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisHepatology, 1981